Oncolytic adenoviruses armed with TNFα and IL-2 enable successful adoptive T-cell therapy of solid tumors

被引：0
|
作者：
Parviainen, S. [1 ]
Havunen, R. [2 ]
Siurala, M. [1 ]
Tahtinen, S. [2 ]
Saha, D. [2 ]
Vaha-Koskela, M. [2 ]
Behr, M. [2 ]
Nettelbeck, D. [3 ]
Ehrhardt, A. [4 ]
Hemminki, A. [1 ]
机构：
[1] TILT Biotherapeut Ltd, Helsinki, Finland
[2] Univ Helsinki, Haartman Inst, Med, Canc Gene Therapy Grp, Helsinki, Finland
[3] German Canc Res Ctr, Oncolyt Adenovirus Grp, Heidelberg, Germany
[4] Univ Witten Herdecke, Fak Gesundheit, Witte, Germany
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2PD
引用
收藏
页码：1 / 1
页数：1
相关论文
共 50 条
  • [21] Characterization of T-cell therapy enhancing oncolytic adenoviruses with human cytokine expression
    Havunen, Riikka
    Parviainen, Suvi
    Siurala, Mikko
    Hemminki, Akseli
    CANCER IMMUNOLOGY RESEARCH, 2015, 3 (10)
  • [22] Tumor Antigen Heterogeneity: The "Elephant in the Room" of Adoptive T-cell Therapy for Solid Tumors
    Albelda, Steven M.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (01) : 2 - 2
  • [23] Adoptive T-cell therapy for the treatment of solid tumours
    Knutson, KL
    Almand, B
    Mankoff, DA
    Schiffman, K
    Disis, ML
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (01) : 55 - 66
  • [24] Adoptive T-Cell Therapy for Cheek for Solid Malignancies
    Jafferji, Mohammad S.
    Yang, James C.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2019, 28 (03) : 465 - +
  • [25] TNFa and IL-2 armed adenoviruses enable complete responses by anti-PD-1 checkpoint blockade
    Cervera-Carrascon, V.
    Siurala, M.
    Santos, J. M.
    Havunen, R.
    Tahtinen, S.
    Karell, P.
    Sorsa, S.
    Kanerva, A.
    Hemminki, A.
    ONCOIMMUNOLOGY, 2018, 7 (05):
  • [26] Clinical application of adoptive T cell therapy in solid tumors
    Zang, Yi-Wen
    Gu, Xiao-Dong
    Xiang, Jian-Bin
    Chen, Zong-You
    MEDICAL SCIENCE MONITOR, 2014, 20 : 953 - 959
  • [27] T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma
    Tahtinen, Siri
    Blattner, Carolin
    Vaha-Koskela, Markus
    Saha, Dipongkor
    Siurala, Mikko
    Parviainen, Suvi
    Utikal, Jochen
    Kanerva, Anna
    Umansky, Viktor
    Hemminki, Akseli
    JOURNAL OF IMMUNOTHERAPY, 2016, 39 (09) : 343 - 354
  • [28] Emerging Data from the Use of TILT-123, an Oncolytic Adenovirus Armed with TNFa and IL-2 in Patients with Solid Tumors
    Cervera-Carrascon, Victor
    Svane, Inge Marie
    Alanko, Tuomo
    Peltola, Katriina
    Dreno, Brigitte
    Donia, Marco
    Ellebaek, Eva
    Monberg, Tine
    Sormunen, Jorma
    Kononen, Juha
    Korpisaari, Riitta
    Jaakola, Marjut
    Khammari, Amir
    Juteau, Susanna
    Clubb, James
    Pakola, Santeri
    Haybout, Lyna
    Santos, Joao M.
    Havunen, Riikka
    Sorsa, Suvi
    Hemminki, Akseli
    MOLECULAR THERAPY, 2023, 31 (04) : 154 - 155
  • [29] Armed with IL-2 based fusion protein improves CAR-T cell fitness and efficacy against solid tumors
    Li, Sijin
    Xia, Yifei
    Hou, Rui
    Wang, Xu
    Zhao, Xuan
    Guan, Zhangchun
    Ma, Wen
    Zhang, Wei
    Liu, Dan
    Zheng, Junnian
    Shi, Ming
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2024, 1870 (05):
  • [30] Aging impairs CD8 T cell responses in adoptive T-cell therapy against solid tumors
    Kadyrzhanova, Gulfiya
    Tamai, Miho
    Sarkar, Shukla
    Kalra, Rajkumar Singh
    Ishikawa, Hiroki
    FRONTIERS IN IMMUNOLOGY, 2025, 16
12345